Endocan is the next stage of innovative cannabinoid-based solutions, with a focus on the health needs of people today. Globally, the diagnoses of critical ailments such as HIV/AIDS, cancer, autoimmune disease, high blood pressure, dementia, and more are arising. Despite scientific advances, we are facing a situation in which millions of people continue to be affected by life-threatening conditions with no truly effective means of treating them. The world needs smart science and research, strong leadership, and new products to respond to ever growing medical need.
Endocan utilizes the unique and potent benefits of cannabinoids, the natural compounds found in the Cannabis plants, from which cannabis and hemp are produced. Cannabinoid based products are potentially the ideal solution for many conditions and diseases.
ENDO Detailed Quote
|Day's Range:||0.01 - 0.02|
|52wk Range:||0.00 - 0.09|
ENDO Recent Headlines
- Watch Beaten-Down Drug Companies, Hospitals in 2017 12/29/2016 09:00 PM
- Could Trump Tax Cut Plans, Republican Congress Spur Biotech M&A? 11/10/2016 09:01 PM
- OMNICANNA HEALTH SOLUTIONS, INC. Files SEC form 8-K, Change in Directors or Principal Officers 09/20/2016 05:26 PM
- Cramer: Collateral Damage Is Giving These Stocks a Bad Name 05/06/2016 11:01 PM
- 'Toxic' Endo International Falls 40% on Slashed Guidance 05/06/2016 07:52 PM